R. Ng

Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer

Penelope A. Bradbury, Dongsheng Tu, Lesley Seymour et al. · JNCI Journal of the National Cancer Institute · 2010 · 76 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +16

Addressing Gaps for Health Systems Strengthening: A Public Perspective on Health Systems’ Response towards COVID-19

Nur Zahirah Balqis-Ali, Weng Hong Fun, Munirah Ismail et al. · International Journal of Environmental Research and Public Health · 2021 · 34 citations · Full text

Nursing, Health Services Administration, Health Systems +13

Long-term outcome and quality of life after supercharged jejunal interposition for oesophageal replacement

Cara Baker, Matthew Forshaw, James Gossage et al. · The Surgeon · 2014 · 31 citations

Medicine, Surgery, Gastroenterology +12

An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancer

Anne M. Horgan, Penelope A. Bradbury, Eitan Amir et al. · Annals of Oncology · 2011 · 29 citations

Medicine, Oncology, Pharmacoeconomics +17

The acute management and surgical reconstruction following failed esophagectomy in malignant disease of the esophagus

H Dowson, R. Ng, Robert C. Mason · Diseases of the Esophagus · 2007 · 20 citations · Full text

Medicine, Surgery, General Surgery +14